Stock Events

Stock Events

ProstaLund AB. 

0
0
+SEK0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

7NovExpected
Q2 2025
Q3 2025
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Baxter International
BAX
Mkt Cap13.51B
Baxter International Inc. offers medical devices and therapies that compete in the urology and prostate health market, similar to ProstaLund's core focus.
Medtronic
MDT
Mkt Cap116.77B
Medtronic plc provides medical technologies, services, and solutions, including treatments for urological disorders, directly competing with ProstaLund's products.
Boston Scientific
BSX
Mkt Cap67.88B
Boston Scientific Corporation specializes in medical devices that are used in various therapies including those for urological health, competing with ProstaLund.
Intuitive Surgical
ISRG
Mkt Cap131.63B
Intuitive Surgical, Inc. offers robotic-assisted surgical systems, some of which are used for prostate surgeries, competing with ProstaLund's treatment options.
Danaher
DHR
Mkt Cap151.89B
Danaher Corporation's medical division offers products and technologies that compete in the broader medical device market, including urology.
Edwards Lifesciences
EW
Mkt Cap52B
Edwards Lifesciences Corporation is involved in patient-focused medical innovations for structural heart disease and critical care monitoring, competing in the medical device sector.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson engages in the research and development, manufacture and sale of a broad range of products in the healthcare field, indirectly competing with ProstaLund through its medical devices segment.

About

ProstaLund AB (publ), a medical technology company, develops, manufactures, and sells urological devices and treatments in Sweden and internationally. It offers CoreTherm, a heat treatment for benign prostate enlargement; CoreFlow, a temporary prostate stent; Oruflow, a urine flow meter; and Schelin Catheter, a medical device intended for intraprostatic and periprostatic injection of legally market drugs. Its products are used in hospitals and clinics. The company was founded in 1991 and is based in Lund, Sweden. ProstaLund AB (publ) is a subsidiary of Farstorps Gard Forvaltnings AB.
Show more...
CEO
Ms. Annette Colin
Employees
6
Country
Sweden
ISIN
SE0022240164

Listings

ST
SE
PLUN-BT-UN.ST

0 Comments

Share your thoughts

FAQ

What is ProstaLund AB. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Stockholm Exchange exchange ProstaLund AB. stocks are traded under the ticker PLUN-BT-UN.ST.
How many employees does ProstaLund AB. have?▼
As of September 04, 2026, the company has 6 employees.
In which sector is ProstaLund AB. located?▼
ProstaLund AB. operates in the Health & Wellness sector.
When did ProstaLund AB. complete a stock split?▼
ProstaLund AB. has not had any recent stock splits.
Where is ProstaLund AB. headquartered?▼
ProstaLund AB. is headquartered in Lund, Sweden.